Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2830-2840
Published online before print November 19, 2007, doi: 10.1161/CIRCULATIONAHA.107.728303
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/24/2830    most recent
CIRCULATIONAHA.107.728303v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Aoki, T.
Right arrow Articles by Hashimoto, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, T.
Right arrow Articles by Hashimoto, N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Other Vascular biology
Right arrow Animal models of human disease
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrowRelated Article

(Circulation. 2007;116:2830-2840.)
© 2007 American Heart Association, Inc.


Stroke

NF-{kappa}B Is a Key Mediator of Cerebral Aneurysm Formation

Tomohiro Aoki, MD; Hiroharu Kataoka, MD, PhD; Munehisa Shimamura, MD, PhD; Hironori Nakagami, MD, PhD; Kouji Wakayama, MD; Takuya Moriwaki, MD, PhD; Ryota Ishibashi, MD; Kazuhiko Nozaki, MD, PhD; Ryuichi Morishita, MD, PhD; Nobuo Hashimoto, MD, PhD

From the Department of Neurosurgery, Kyoto University, Graduate School of Medicine, Kyoto (T.A., H.K., T.M., R.I., K.N., N.H.); Department of Advanced Clinical Science and Therapeutics, Tokyo University, Graduate School of Medicine, Tokyo (M.S., K.W.); and Department of Clinical Gene Therapy, Osaka University, Graduate School of Medicine, Osaka (H.N., R.M.), Japan.

Correspondence to Hiroharu Kataoka, MD, PhD, Department of Neurosurgery, Kyoto University, Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606–8507, Japan. E-mail kataoka{at}kuhp.kyoto-u.ac.jp

Received July 17, 2007; accepted October 9, 2007.

Background— Subarachnoid hemorrhage caused by the rupture of cerebral aneurysm (CA) remains a life-threatening disease despite recent diagnostic and therapeutic advancements. Recent studies strongly suggest the active participation of macrophage-mediated chronic inflammatory response in the pathogenesis of CA. We examined the role of nuclear factor-{kappa}B (NF-{kappa}B) in the pathogenesis of CA formation in this study.

Methods and Results— In experimentally induced CAs in rats, NF-{kappa}B was activated in cerebral arterial walls in the early stage of aneurysm formation with upregulated expression of downstream genes. NF-{kappa}B p50 subunit–deficient mice showed a decreased incidence of CA formation with less macrophage infiltration into the arterial wall. NF-{kappa}B decoy oligodeoxynucleotide also prevented CA formation when it was administered at the early stage of aneurysm formation in rats. Macrophage infiltration and expression of downstream genes were dramatically inhibited by NF-{kappa}B decoy oligodeoxynucleotide. In human CA walls, NF-{kappa}B also was activated, especially in the intima.

Conclusions— Our data indicate that NF-{kappa}B plays a crucial role as a key regulator in the initiation of CA development by inducing some inflammatory genes related to macrophage recruitment and activation. NF-{kappa}B may represent a therapeutic target of a novel medical treatment for CA.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 116: 2773. [Full Text]